Patents Assigned to AKER BIOMARINE ANTARCTIC AS
-
Patent number: 10028968Abstract: A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.Type: GrantFiled: September 8, 2016Date of Patent: July 24, 2018Assignee: AKER BIOMARINE ANTARCTIC ASInventor: Fotini Sampalis
-
Patent number: 10010567Abstract: This disclosure discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: May 8, 2017Date of Patent: July 3, 2018Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9889163Abstract: Krill oil compositions are disclosed as having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: May 8, 2017Date of Patent: February 13, 2018Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9867856Abstract: The invention provides improved processes for extracting and preparing polar lipids (in particular, desirable phospholipids) from krill and other biological sources. The inventors have discovered processes through which it is possible to extract phospholipids to give high phospholipid content and a reduction of undesired components.Type: GrantFiled: January 9, 2015Date of Patent: January 16, 2018Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Finn Myhren, Nils Hoem, Håvard Thøgersen
-
Patent number: 9816046Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: May 8, 2017Date of Patent: November 14, 2017Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Publication number: 20170182073Abstract: Oral capsules have been dismissed as a dosage form for delivery high dosages of krill phospholipids, but by purifying these to high levels it is indeed possible to use this dosage form to deliver, for example, 700 mg or more phospholipids per capsule.Type: ApplicationFiled: February 12, 2015Publication date: June 29, 2017Applicant: Aker BioMarine Antarctic ASInventors: Stefan Hupfeld, Tove Julie Evjen, Finn Myhren, Håvard Thøgersen
-
Patent number: 9644169Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: June 13, 2016Date of Patent: May 9, 2017Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9644170Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: June 13, 2016Date of Patent: May 9, 2017Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Publication number: 20170043022Abstract: Oil-in-water emulsions are prepared using phospholipids purified from krill.Type: ApplicationFiled: April 24, 2015Publication date: February 16, 2017Applicant: Aker BioMarine Antarctic ASInventor: Stefan Hupfeld
-
Patent number: 9375453Abstract: New krill oil compositions are disclosed as having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obatined are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: September 6, 2013Date of Patent: June 28, 2016Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9320765Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: September 6, 2013Date of Patent: April 26, 2016Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9295683Abstract: The invention relates to omega-3 phospholipid supplements for use in adolescents, and in particular to use omega-3 phospholipid supplements to improve or support brain maturity age. In preferred embodiments, the omega-3 phospholipid is krill oil.Type: GrantFiled: March 11, 2014Date of Patent: March 29, 2016Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Kjetil Berge, Lena Burri
-
Patent number: 9220735Abstract: This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders.Type: GrantFiled: April 3, 2014Date of Patent: December 29, 2015Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Jeffery Cohn, Mikko Griinari, Sebastiano Banni, Daniele Mancinelli, Nils Hoem, Hogne Vik
-
Patent number: 9119864Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: February 12, 2015Date of Patent: September 1, 2015Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9078905Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: September 18, 2014Date of Patent: July 14, 2015Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9072752Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: February 12, 2015Date of Patent: July 7, 2015Assignee: AKER BIOMARINE ANTARCTIC ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Patent number: 9028877Abstract: This invention discloses new krill oil compositions characterized by having high amounts of phospholipids, astaxanthin esters and/or omega-3 contents. The krill oils are obtained from krill meal using supercritical fluid extraction in a two stage process. Stage 1 removes the neutral lipid by extracting with neat supercritical CO2 or CO2 plus approximately 5% of a co-solvent. Stage 2 extracts the actual krill oils by using supercritical CO2 in combination with approximately 20% ethanol. The krill oil materials obtained are compared with commercially available krill oil and found to be more bioeffective in a number of areas such as anti-inflammation, anti-oxidant effects, improving insulin resistances and improving blood lipid profile.Type: GrantFiled: September 18, 2014Date of Patent: May 12, 2015Assignee: Aker Biomarine Antarctic ASInventors: Inge Bruheim, Snorre Tilseth, Daniele Mancinelli
-
Publication number: 20150030718Abstract: The present invention provides a chewable oral delivery vehicle comprising a chewable matrix and at least one soft gelatin capsule encapsulating an oxidizable fatty acid composition, wherein the at least one soft gelatin capsule is incorporated into the chewable matrix. The chewable matrix may be a gummy candy or jelly sweet. The oxidizable fatty acid composition may be a free fatty acid composition, fatty acid ester composition, glyceride composition, phospholipid composition or combinations thereof, and preferably comprise one or more fatty acids or residues thereof selected from the group consisting of eicosapentaenoic-, docosahexaenoic-, docosapentaenoic-, conjugated linoleic-, palmitoleic-, trans palmitoleic-, alpha linolenic-, gamma linolenic-, and stearidonic acid and combinations thereof.Type: ApplicationFiled: March 11, 2013Publication date: January 29, 2015Applicant: AKER BIOMARINE ANTARCTIC ASInventor: Asgeir Saebo